Granulocytes, platelets, bone marrow and other hematopoietic cells

This entry describes the hematopoietic system, which includes the bone marrow and the various blood cell lineages it produces, such as granulocytes and platelets. Granulocytes, including neutrophils, eosinophils, and basophils, are essential for the innate immune response and inflammatory processes (StatPearls: Hematopoiesis). Platelets, or thrombocytes, are critical for maintaining hemostasis and initiating blood clot formation (NIH: Blood Cells). The bone marrow acts as the primary site for hematopoiesis, where hematopoietic stem cells differentiate into mature blood cells under the influence of various cytokines and growth factors (PubMed: PMC3666477). While not a single molecular target, this system is frequently the focus of therapeutic intervention, such as using G-CSF to treat neutropenia or erythropoietin for anemia. Additionally, the hematopoietic system is a major site of dose-limiting toxicity for many cytotoxic drugs, leading to conditions like myelosuppression. Because this term encompasses multiple cell types and tissues, it does not represent a specific protein or receptor target.

Other names

Hematopoietic systemMyeloid and lymphoid lineagesBlood-forming organsHematopoietic compartment

Drugs interact with this system by either stimulating lineage-specific production via cytokine receptors (e.g., G-CSFR, EPOR), depleting rapidly dividing cells through DNA damage or antimetabolite activity, or modulating the bone marrow microenvironment.